Publications:

Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.

Therapeutic Advances In Medical Oncology

de Rauglaudre, Bernadette B; Sibertin-Blanc, Camille C; Fabre, Aurélie A; Le Malicot, Karine K; Bennouna, Jaafar J; Ghiringhelli, François F; Taïeb, Julien J; Boige, Valérie V; Bouché, Olivier O; Chatellier, Thierry T; Faroux, Roger R; François, Eric E; Jacquot, Stéphane S; Genet, Dominique D; Mulot, Claire C; Olschwang, Sylviane S; Seitz, Jean-François JF; Aparicio, Thomas T; Dahan, Laetitia L

Publication Date: 2022

Variant appearance in text: EGFR: 1416A>T

PubMed Link: 36601631

Variant Present in the following documents:

• 10.1177_17588359221141307.pdf

View BVdb publication page

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.

Cancer Drug Resistance (Alhambra, Calif.)

Alonso-Peña, Marta M; Sanchez-Martin, Anabel A; Sanchon-Sanchez, Paula P; Soto-Muñiz, Meraris M; Espinosa-Escudero, Ricardo R; Marin, Jose J G JJG

Publication Date: 2019

Variant appearance in text: EGFR: 1416A>T

PubMed Link: 35582588

Variant Present in the following documents:

• Main text
• cdr-2-680.pdf

View BVdb publication page

A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.

International Journal Of Immunogenetics

Karakas Celik, Sevim S; Cakmak Genc, Gunes G; Dursun, Ahmet A

Publication Date: 2021-04

Variant appearance in text: EGFR: 1416A>T

PubMed Link: 33246355

Variant Present in the following documents:

• IJI-9999-na.pdf

View BVdb publication page

The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.

Nature Communications

Inman, Gareth J GJ; Wang, Jun J; Nagano, Ai A; Alexandrov, Ludmil B LB; Purdie, Karin J KJ; Taylor, Richard G RG; Sherwood, Victoria V; Thomson, Jason J; Hogan, Sarah S; Spender, Lindsay C LC; South, Andrew P AP; Stratton, Michael M; Chelala, Claude C; Harwood, Catherine A CA; Proby, Charlotte M CM; Leigh, Irene M IM

Publication Date: 2018-09-10

Variant appearance in text: EGFR: A472A

PubMed Link: 30202019

Variant Present in the following documents:

• 41467_2018_6027_MOESM5_ESM.xlsx, sheet 1

View BVdb publication page

Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed.

Oncotarget

Wei, Lai L; Wang, Lizhi L; Liu, Ziye Z; Wang, Meiyi M; Lu, Weili W; Zhao, Dewei D; Yang, Bin B; Kong, Xuejun X; Ding, Yan Y; Wang, Zhiqiang Z

Publication Date: 2017-08-22

Variant appearance in text: EGFR: 1416A>T

PubMed Link: 28915721

Variant Present in the following documents:

• Main text
• oncotarget-08-57898.pdf

View BVdb publication page